We focus on
KEEPING YOU UPDATED

Updates & Articles

Here you will find the latest updates from SERB and any relevant articles to our product areas.

Mar 30 2021
SERB completes acquisition of BTG Specialty Pharmaceuticals to create a global leader in critical care medicines

SERB Specialty Pharmaceuticals (“SERB”), a leading European specialty pharmaceutical group focused on prescription medicines that address rare and life-threatening diseases, today announced the acquisition of BTG Specialty Pharmaceuticals, a division of Boston Scientific that develops, manufactures, and commercializes antidotes and rescue medicines to treat patients with critical conditions.

Read More
Mar 30 2021
SERB acquires Veriton Pharma

SERB expands presence in UK specialty pharmaceuticals and strengthens its neurology and rare disease franchise with the acquisition of Veriton Pharma.

Read More